how long will semaglutide be on the shortage list Drug prescribed for type 2 diabetes in short supply over weight-loss hype Troubling Findings in Study of

I was very sad

Key facts OptumRx's standard formulary covers Wegovy for cardiovascular risk reduction only (since January 2025)

Compared to bupropion-naltrexone, patients on GLP-1 agonists medication had nine times higher risk of pancreatitis (inflammation of the pancreas), four times higher risk of bowel obstruction (food is prevented from passing through the small intestine) and three times higher risk of stomach paralysis

They work by helping the body release insulin and reduce glucagon production after meals

Nearly 6 percent of adults now use GLP-1s, and side effects like nausea, constipation, and abdominal discomfort are common

doi: 10.3389/fendo.2022.928016 56 BranumGDBowersBAWattersCRHaebigJCucchiaroGFaroukMet al